WBR0058: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{WBRQuestion |QuestionAuthor=William J Gibson |ExamType=USMLE Step 1 |MainCategory=Microbiology |SubCategory=General Principles, Infectious Disease |MainCategory=Microbiology...")
 
m (refreshing WBR questions)
 
(11 intermediate revisions by 3 users not shown)
Line 1: Line 1:
{{WBRQuestion
{{WBRQuestion
|QuestionAuthor=William J Gibson
|QuestionAuthor=William J Gibson (Reviewed by Yazan Daaboul)
|ExamType=USMLE Step 1
|ExamType=USMLE Step 1
|MainCategory=Microbiology
|MainCategory=Microbiology, Pharmacology
|SubCategory=General Principles, Infectious Disease
|SubCategory=Dermatology, General Principles, Infectious Disease
|MainCategory=Microbiology
|MainCategory=Microbiology, Pharmacology
|SubCategory=General Principles, Infectious Disease
|SubCategory=Dermatology, General Principles, Infectious Disease
|MainCategory=Microbiology
|MainCategory=Microbiology, Pharmacology
|SubCategory=General Principles, Infectious Disease
|SubCategory=Dermatology, General Principles, Infectious Disease
|MainCategory=Microbiology
|MainCategory=Microbiology, Pharmacology
|MainCategory=Microbiology
|MainCategory=Microbiology, Pharmacology
|SubCategory=General Principles, Infectious Disease
|MainCategory=Microbiology, Pharmacology
|MainCategory=Microbiology
|SubCategory=Dermatology, General Principles, Infectious Disease
|SubCategory=General Principles, Infectious Disease
|MainCategory=Microbiology, Pharmacology
|MainCategory=Microbiology
|SubCategory=Dermatology, General Principles, Infectious Disease
|SubCategory=General Principles, Infectious Disease
|MainCategory=Microbiology, Pharmacology
|MainCategory=Microbiology
|SubCategory=Dermatology, General Principles, Infectious Disease
|SubCategory=General Principles, Infectious Disease
|MainCategory=Microbiology, Pharmacology
|MainCategory=Microbiology
|SubCategory=Dermatology, General Principles, Infectious Disease
|MainCategory=Microbiology
|MainCategory=Microbiology, Pharmacology
|SubCategory=General Principles, Infectious Disease
|MainCategory=Microbiology, Pharmacology
|Prompt=A 39 year old woman presents to your office complaining of fever, muscle soreness, headache and severe malaise one week after returning from a summer vacation on Cape Cod. She shows you a red rash on her leg with a inner ring clearing resembling a bullseye. What is the optimal treatment for this patient?
|SubCategory=Dermatology, General Principles, Infectious Disease
|Explanation=The patient in this vignette has the early stages of Lyme disease caused by the spirochete Borrelia burgdorferi. Lyme disease is caused by the organism Borrelia Burgdorferi, a bacteria which is carried by the Ixodes tick. In its early stages, Lyme disease causes a characteristic “bullseye” rash called erythema chronicum migrans in 80% of patients. Most patients exhibit flu-like symptoms in the early stages of infection.  Tetracyline antibiotics such as doxycycline are used for Lyme disease and have the advantage that they are effective against human granulocytic anaplasmosis, an infectious disease caused by Anaplasma phagocytophilum which also uses the Ixodes tick as its vector (among others).
|Prompt=A 27-year-old woman presents to her primary care physician complaining of fever, flu-like symptoms, and a rash. She recently returned from a camping trip in Boston. Physical examination is remarkable for erythema chronicum migrans. What is the optimal treatment for this patient?
|Explanation=The patient in this vignette has the early (primary) stage of Lyme disease, caused by the spirochete ''Borrelia burgdorferi''. ''Borrelia burgdorferi'' is a zoonotic bacteria that is carried by the Ixodes (deer) tick. In its early stages, Lyme disease causes flu-like symptoms and a characteristic “bullseye” rash called erythema chronicum migrans present in 80% of patients. The incubation period of Lyme disease can vary greatly, but is typically 1 to 2 weeks.  


Educational Objective: Lyme disease is treated with tetracycline antibiotics (or for later disseminated stage, a third generation cephalosporin such as ceftriaxone).
If untreated, Lyme disease can cause facial palsy and AV nodal block (secondary Lyme disease) progressing to chronic monoarthritis or migratory polyarthritis (tertiary Lyme disease). It is endemic to Northeastern USA. Treatment is generally by doxycyline.
References:  First Aid 2012 page 165. IDSA Guidelines: http://cid.oxfordjournals.org/content/43/9/1089.full
 
Tags: #Microbiology #Pharmacology
[[File:Cell antibiotics.jpg|1200px]]
|AnswerA=Erythromycin
|AnswerA=Erythromycin
|AnswerAExp=Incorrect - Erythromycin is a macrolide used to treat atypical pneumonias
|AnswerAExp=Erythromycin is a macrolide used to treat atypical pneumonias
|AnswerB=Doxycycline
|AnswerB=Doxycycline
|AnswerBExp=Correct - Doxyclince is a tetracycline used to treat Lyme disease.
|AnswerBExp=Doxyclince is a tetracycline used to treat Lyme disease.
|AnswerC=Penicillin
|AnswerC=Penicillin
|AnswerCExp=Incorrect - Penicillin is a beta-lactam antibiotic used o treat gram-positive organisms and syphillis.
|AnswerCExp=Penicillin is a beta-lactam antibiotic used to treat some gram-positive organisms, some gram-negative organisms, and syphilis.
|AnswerD=Trimethoprim-Sulfamethoxazole
|AnswerD=Trimethoprim-Sulfamethoxazole (TMP-SMX)
|AnswerDExp=Incorrect - Trimethoprim-Sulfamethoxazole (Bactrim) inhibits dihyrofolate reductase and is used to treat UTIs
|AnswerDExp=Trimethoprim-Sulfamethoxazole (TMP-SMX) inhibits dihyrofolate reductase and may used to treat UTIs, and ''Pneumocystis jirovecii'' infection in HIV-positive patients.
|AnswerE=Ciprofloxacin
|AnswerE=Ciprofloxacin
|AnswerEExp=Incorrect - Ciprofloxacin is a fluoroquinolone which inhibits DNA gyrase and is used to treat gram-negative rods
|AnswerEExp=Ciprofloxacin is a fluoroquinolone which inhibits DNA gyrase and is used to treat gram-negative rods and ''Pseudomonas aeruginosa''.
|EducationalObjectives=Primary (early) lyme disease is optimally treated with tetracycline antibiotics, such as doxycycline.
|References=First Aid 2014 page 141
|RightAnswer=B
|RightAnswer=B
|Approved=No
|WBRKeyword=Microbiology, Zoonotic, Animal, Tick, Lyme disease, Lyme, Bacteria, Rash, Dermatology, Pharmacology, Drugs, Antibiotics, Linked
|Approved=Yes
}}
}}

Latest revision as of 23:11, 27 October 2020

 
Author PageAuthor::William J Gibson (Reviewed by Yazan Daaboul)
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Microbiology, MainCategory::Pharmacology
Sub Category SubCategory::Dermatology, SubCategory::General Principles, SubCategory::Infectious Disease
Prompt [[Prompt::A 27-year-old woman presents to her primary care physician complaining of fever, flu-like symptoms, and a rash. She recently returned from a camping trip in Boston. Physical examination is remarkable for erythema chronicum migrans. What is the optimal treatment for this patient?]]
Answer A AnswerA::Erythromycin
Answer A Explanation AnswerAExp::Erythromycin is a macrolide used to treat atypical pneumonias
Answer B AnswerB::Doxycycline
Answer B Explanation AnswerBExp::Doxyclince is a tetracycline used to treat Lyme disease.
Answer C AnswerC::Penicillin
Answer C Explanation AnswerCExp::Penicillin is a beta-lactam antibiotic used to treat some gram-positive organisms, some gram-negative organisms, and syphilis.
Answer D AnswerD::Trimethoprim-Sulfamethoxazole (TMP-SMX)
Answer D Explanation AnswerDExp::Trimethoprim-Sulfamethoxazole (TMP-SMX) inhibits dihyrofolate reductase and may used to treat UTIs, and ''Pneumocystis jirovecii'' infection in HIV-positive patients.
Answer E AnswerE::Ciprofloxacin
Answer E Explanation AnswerEExp::Ciprofloxacin is a fluoroquinolone which inhibits DNA gyrase and is used to treat gram-negative rods and ''Pseudomonas aeruginosa''.
Right Answer RightAnswer::B
Explanation [[Explanation::The patient in this vignette has the early (primary) stage of Lyme disease, caused by the spirochete Borrelia burgdorferi. Borrelia burgdorferi is a zoonotic bacteria that is carried by the Ixodes (deer) tick. In its early stages, Lyme disease causes flu-like symptoms and a characteristic “bullseye” rash called erythema chronicum migrans present in 80% of patients. The incubation period of Lyme disease can vary greatly, but is typically 1 to 2 weeks.

If untreated, Lyme disease can cause facial palsy and AV nodal block (secondary Lyme disease) progressing to chronic monoarthritis or migratory polyarthritis (tertiary Lyme disease). It is endemic to Northeastern USA. Treatment is generally by doxycyline.


Educational Objective: Primary (early) lyme disease is optimally treated with tetracycline antibiotics, such as doxycycline.
References: First Aid 2014 page 141]]

Approved Approved::Yes
Keyword WBRKeyword::Microbiology, WBRKeyword::Zoonotic, WBRKeyword::Animal, WBRKeyword::Tick, WBRKeyword::Lyme disease, WBRKeyword::Lyme, WBRKeyword::Bacteria, WBRKeyword::Rash, WBRKeyword::Dermatology, WBRKeyword::Pharmacology, WBRKeyword::Drugs, WBRKeyword::Antibiotics, WBRKeyword::Linked
Linked Question Linked::
Order in Linked Questions LinkedOrder::